A novel histone deacetylase inhibitor prevents IL-1β induced metabolic dysfunction in pancreatic β-cells

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 8 B, 2009, Pages 1877-1885

  Susick, Laura ^a   Senanayake, Thulani ^a   Veluthakal, Rajakrishnan ^a   Woster, Patrick M ^a   Kowluru, Anjaneyulu ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

HDAC inhibitors; Inducible nitric oxide synthase; NF B; NO release; Pancreatic cell

Indexed keywords

EID: 70349152864     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00672.x     Document Type: Article

References (40)

1. Khan N, Jeffers M, Kumar S, et al. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem J. 2008 409 : 581 589.
2. Varghese S, Senanayake T, Murray-Stewart T, et al. Polyaminohydroxamic acids and polyaminobenzamides as isoform selective histone deacetylase inhibitors. J Med Chem. 2008 51 : 2447 2456.
3. Baradari V, Huether A, Hopfner M, et al. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells. Endocr Relat Cancer. 2006 13 : 1237 1250.
4. Camelo S, Iglesias AH, Hwang D, et al. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. J Neuroimmunol. 2005 164 : 10 21.
5. Reddy RM, Yeow WS, Chua A, et al. Rapid and profound potentiation of Apo2L/TRAIL-mediated cytotoxicity and apoptosis in thoracic cancer cells by the histone deacetylase inhibitor Trichostatin A: the essential role of the mitochondria-mediated caspase activation cascade. Apoptosis. 2007 12 : 55 71.
6. Taghiyev AF, Guseva NV, Glover RA, et al. TSA-induced cell death in prostate cancer cell lines is caspase-2 dependent and involves the PIDDosome. Cancer Biol Ther. 2006 5 : 1199 1205.
7. Huber LC, Brock M, Hemmatazad H, et al. Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis Rheum. 2007 56 : 1087 1093.
8. Lin HS, Hu CY, Chan HY, et al. Anti- rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents. Br J Pharmacol. 2007 150 : 862 872.
9. Huang L. Targeting histone deacetylases for the treatment of cancer and inflammatory diseases. J Cell Physiol. 2006 209 : 611 616.
10. Blanchard F, Chipoy C. Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases Drug Discov Today. 2005 10 : 197 204.
11. Chakrabarti SK, Francis J, Ziesmann SM, et al. Covalent histone modifications underlie the developmental regulation of insulin gene transcription in pancreatic beta cells. J Biol Chem. 2003 278 : 23617 23623.
12. Mosley AL, Corbett JA, Ozcan S. Glucose regulation of insulin gene expression requires the recruitment of p300 by the beta-cell-specific transcription factor Pdx-1. Mol Endocrinol. 2004 18 : 2279 2290.
13. Mosley AL, Ozcan S. Glucose regulates insulin gene transcription by hyperacetylation of histone H4. J Biol Chem. 2003 278 : 19660 19666.
14. Larsen L, Tonnesen M, Ronn SG, et al. Inhibition of histone deacetylases prevents cytokine-induced toxicity in beta cells. Diabetologia. 2007 50 : 779 789.
15. Susick L, Veluthakal R, Suresh MV, et al. Regulatory roles for histone deacetylation in IL-1beta-induced nitric oxide release in pancreatic beta-cells. J Cell Mol Med. 2008 12 : 1571 1583.
16. Varghese S, Gupta D, Baran T, et al. Alkyl-substituted polyaminohydroxamic acids: a novel class of targeted histone deacetylase inhibitors. J Med Chem. 2005 48 : 6350 6365.
17. McDonald P, Veluthakal R, Kaur H, et al. Biologically active lipids promote trafficking and membrane association of Rac1 in insulin-secreting INS 832/13 cells. Am J Physiol Cell Physiol. 2007 292 : C1216 20.
18. Veluthakal R, Kaur H, Goalstone M, et al. Dominant-negative alpha-subunit of farnesyl- and geranyltransferase inhibits glucose-stimulated, but not KCl-stimulated, insulin secretion in INS 832/13 cells. Diabetes. 2007 56 : 204 210.
19. Chen HQ, Tannous M, Veluthakal R, et al. Novel roles for palmitoylation of Ras in IL-1 beta-induced nitric oxide release and caspase 3 activation in insulin-secreting beta cells. Biochem Pharmacol. 2003 66 : 1681 1694.
20. Tannous M, Amin R, Popoff MR, et al. Positive modulation by Ras of interleukin-1beta-mediated nitric oxide generation in insulin-secreting clonal beta (HIT-T15) cells. Biochem Pharmacol. 2001 62 : 1459 1468.
21. +. Diabetes. 2005 54 : 2576 2585.
22. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 72 : 248 254.
23. Eizirik DL, Mandrup-Poulsen T. A choice of death-the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia. 2001 44 : 2115 2133.
24. Mandrup-Poulsen T. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia. 1996 39 : 1005 1029.
25. Rabinovitch A, Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol. 1998 55 : 1139 1149.
26. Eberharter A, Becker PB. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep. 2002 3 : 224 229.
27. Horn PJ, Peterson CL. Molecular biology. Chromatin higher order folding-wrapping up transcription. Science. 2002 297 : 1824 1827.
28. Allfrey VG, Faulkner R, Mirsky AE. Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci U S A. 1964 51 : 786 794.
29. Wang R, Cherukuri P, Luo J. Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation. J Biol Chem. 2005 280 : 11528 11534.
30. Yuan ZL, Guan YJ, Chatterjee D, et al. Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science. 2005 307 : 269 273.
31. Zhang Y, Sif S, DeWille J. The mouse C/EBPdelta gene promoter is regulated by STAT3 and Sp1 transcriptional activators, chromatin remodeling and c-Myc repression. J Cell Biochem. 2007 102 : 1256 1270.
32. Granja AG, Sabina P, Salas ML, et al. Regulation of inducible nitric oxide synthase expression by viral A238L-mediated inhibition of p65/RelA acetylation and p300 transactivation. J Virol. 2006 80 : 10487 10496.
33. Horion J, Gloire G, El Mjiyad N, et al. Histone deacetylase inhibitor trichostatin A sustains sodium pervanadate-induced NF-kappaB activation by delaying IkappaBalpha mRNA resynthesis: comparison with tumor necrosis factor alpha. J Biol Chem. 2007 282 : 15383 15393.
34. Hu J, Colburn NH. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding. Mol Cancer Res. 2005 3 : 100 109.
35. Eizirik DL, Cagliero E, Bjorklund A, et al. Interleukin-1 beta induces the expression of an isoform of nitric oxide synthase in insulin-producing cells, which is similar to that observed in activated macrophages. FEBS Lett. 1992 308 : 249 252.
36. Flodstrom M, Welsh N, Eizirik DL. Cytokines activate the nuclear factor kappa B (NF-kappa B) and induce nitric oxide production in human pancreatic islets. FEBS Lett. 1996 385 : 4 6.
37. Pieper CM, Roza AM, Henderson JD, Jr., et al. Spatial distribution and temporal onset of NF-kB activation and inducible nitric oxide synthase within pancreatic islets in the pre-diabetic stage of genetic, diabetic-prone BB rats: attenuation by drug intervention decreases inflammatory cell infiltration and incidence of diabetes. Inflamm Res. 2004 53 : 22 30.
38. Yu Z, Zhang W, Kone BC. Histone deacetylases augment cytokine induction of the iNOS gene. J Am Soc Nephrol. 2002 13 : 2009 2017.
39. Wang J, Mahmud SA, Bitterman PB, et al. Histone deacetylase inhibitors suppress TF-kappaB-dependent agonist-driven tissue factor expression in endothelial cells and monocytes. J Biol Chem. 2007 282 : 28408 28418.
40. Yu Z, Kone BC. Targeted histone H4 acetylation via phosphoinositide 3-kinase- and p70s6-kinase-dependent pathways inhibits iNOS induction in mesangial cells. Am J Physiol Renal Physiol. 2006 290 : F496 502.